Manuja Anju, Kumar Sandeep, Dilbaghi Neeraj, Bhanjana Gaurav, Chopra Meenu, Kaur Harmanmeet, Kumar Rajender, Manuja Balvinder K, Singh Shailendra K, Yadav Suresh C
National Research Center on Equines, Sirsa road, Hisar 125001, Haryana, India.
Nanomedicine (Lond). 2014 Aug;9(11):1625-34. doi: 10.2217/nnm.13.148. Epub 2014 Jan 10.
To reduce the dose, toxic effects and to ensure sustained release of quinapyramine sulfate (QS), a highly effective drug against Trypanosoma evansi.
MATERIALS & METHODS: QS-loaded sodium alginate nanoparticles (QS-NPs) were formed by emulsion-crosslinking technology using dioctyl-sodium-sulfosuccinate and sodium alginate. The formulation was characterized for size, stability, morphology and functional groups by a zetasizer, scanning electron microscopy, atomic force microscopy, transmission electron microscopy and Fourier transform infrared spectroscopy. In vitro safety and toxicity studies were performed by metabolic assay in Vero cell lines, and in vivo efficacy was evaluated in mice.
QS-NPs were <60 nm with 96.48% entrapment efficiency and 3.70% drug loading. The formulation showed an initial burst effect followed by slow drug release in accordance with quasi-Fickian Higuchi diffusion mechanism. QS-NPs were much less toxic and able to clear the parasite at a much lower concentration than QS.
The QS-NPs synthesized are safe, less toxic and highly effective compared with QS.
降低硫酸喹吖因(QS)的剂量、毒性并确保其缓释,QS是一种抗伊氏锥虫的高效药物。
采用乳液交联技术,使用二辛基磺基琥珀酸钠和海藻酸钠制备负载QS的海藻酸钠纳米粒(QS-NPs)。通过zeta电位仪、扫描电子显微镜、原子力显微镜、透射电子显微镜和傅里叶变换红外光谱对制剂的尺寸、稳定性、形态和官能团进行表征。通过在Vero细胞系中的代谢试验进行体外安全性和毒性研究,并在小鼠体内评估疗效。
QS-NPs粒径小于60 nm,包封率为96.48%,载药量为3.70%。该制剂表现出初始突释效应,随后根据准菲克- Higuchi扩散机制缓慢释药。QS-NPs毒性小得多,并且能够在比QS低得多的浓度下清除寄生虫。
与QS相比,合成的QS-NPs安全、低毒且高效。